Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1566, 2006-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
VTE risk included in the new safety information about Evra
Reactions Weekly, Vol. 1, Iss. 1130, 2006-01 ,pp. :
Access to resources
Recommend
Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. :
Third-generation OCs: increased VTE risk supported by new analyses
Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. :
Ximelagatran reduces risk of VTE
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :
Antipsychotics associated with elevated VTE risk
Reactions Weekly, Vol. 1, Iss. 1321, 2010-01 ,pp. :